Yang Ning, Jin Siyan, Ma Linlin, Liu Jia, Shan Chenli, Zhao Jinsong
Department of Ophthalmology, The Second Hospital of Jilin University, Changchun City, China.
J Ophthalmol. 2020 Jul 19;2020:6578750. doi: 10.1155/2020/6578750. eCollection 2020.
Microphthalmos is a type of developmental disorder ophthalmopathy, which can occur isolated or combined with other ocular malformations and can occur secondary to a systemic syndrome. Nanophthalmos is one of the clinical phenotypes of microphthalmos. Due to the special and complex structure of nanophthalmic eyes, the disorder is often associated with many complications, including high hyperopia, angle-closure glaucoma, and uveal effusion syndrome. The management of these complications is challenging, and conventional therapeutic methods are often ineffective in treating them. The purpose of this paper was to review the concept of nanophthalmos and present the latest progress in the study of the pathogenesis and treatment of its complications. As it is considerably challenging for ophthalmologists to prevent or treat these nanophthalmos complications, timely diagnosis and a suitable clinical treatment plan are vital to ensure that nanophthalmos patients are treated and managed effectively.
小眼球是一种发育性障碍眼病,可单独发生或与其他眼部畸形合并出现,也可继发于全身性综合征。小角膜是小眼球的临床表型之一。由于小角膜眼的结构特殊且复杂,该病症常伴有许多并发症,包括高度远视、闭角型青光眼和葡萄膜渗漏综合征。这些并发症的治疗具有挑战性,传统治疗方法往往对其无效。本文旨在综述小角膜的概念,并介绍其并发症发病机制及治疗研究的最新进展。由于眼科医生预防或治疗这些小角膜并发症颇具挑战性,因此及时诊断和制定合适的临床治疗方案对于确保小角膜患者得到有效治疗和管理至关重要。